Todos Medical Acquires Lucrative NLC Assets For Pe
Post# of 1418
"Therefore, it's reasonable to think Todos might generate at least $6 billion in sales of Tollovir. A 3x multiple on this peak sales number will yield $18 billion in valuation; $10.8 billion of value to Todos. "
https://www.benzinga.com/general/biotech/22/0...the-dollar